circRNA and application thereof in preparation of cervical cancer diagnostic reagent
A technology for cervical cancer and reagents, applied in the direction of DNA/RNA fragments, recombinant DNA technology, microbial measurement/inspection, etc., can solve the low incidence of cervical cancer, cervical cancer screening and the heavy burden of primary prevention health economics, etc. problem, to achieve the effect of accurate detection method and high detection accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] Example 1 Data Screening and Integrated Analysis
[0049] The GEO (Gene Expression Omnibus) database is developed and maintained by NCBI (National Center for Biotechnology Information), and the GEO database is the largest database of gene expression data. Develop dataset inclusion criteria:
[0050] ①The selected data set must be genome-wide mRNA / miRNA / circRNA transcriptome data;
[0051] ② These data come from tissues of cervical squamous cell carcinoma (CSCC) case group and control group (N) (without drug stimulation or transfection);
[0052] ③ This study considers standardized or original data sets.
[0053] After screening, the following data sets were obtained:
[0054] Table 1 List of datasets included in screening
[0055]
[0056] data analysis:
[0057] The tool used was R-3.3.3, and the metaMA package was used for analysis. The method used for p-value merging in meta-analysis was the inversenormal method.
[0058] Screening criteria for differentiall...
Embodiment 2
[0063] Example 2 RT-PCR verification of the relative expression of hsa_circ_0000069 in cervical squamous cell carcinoma tissues and adjacent tissues
[0064] 1. Materials
[0065] Tissue samples from 27 patients with cervical squamous cell carcinoma who underwent surgery in the gynecology ward of Shanghai Changning District Maternal and Child Health Hospital were collected, and the corresponding paracancerous tissues of the patients were used as the control group. The pathological diagnosis of the patients was verified by pathologists. None of the patients had received radiotherapy or chemotherapy before operation, and had no other surgical, endocrine, metabolic, infectious diseases and other gynecological diseases such as uterus and ovary. Fresh tissue specimens were obtained under sterile conditions, washed with normal saline to remove blood, and divided into RNase-free cryopreservation tubes, quick-frozen in liquid nitrogen overnight, and stored in a -80°C refrigerator for...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com